Navigation Links
Advances in personalized medicine take center stage
Date:4/27/2010

Kansas City, MO April 28, 2010 Many of the world's leading experts in pediatric pharmacogenomics and personalized medicine are gathering today at a first-of-its-kind conference in Kansas City to change the way childhood diseases and illnesses are treated. The goal of the conference, hosted by Children's Mercy Hospitals and Clinics, is to apply genomic tools to medical problems to tailor treatment to the unique make-up of pediatric patients and improve outcomes.

"Personalized medicine uses recent advancements in genomics and molecular data to help us give the right medication to the right patient, in the right dosage, at the right time," said conference organizer Stephen Spielberg, MD, PhD, Director of the Children's Mercy Center for Personalized Medicine and Therapeutic Innovation; Marion Merrell Dow Chair in Pediatric Pharmacogenomics; and Professor of Pediatrics, University of Missouri-Kansas City School of Medicine. "Currently, many types of medications work for only about half of the people who take them, so personalized medicine has the potential to revolutionize the way we treat illness."

At the April 28-30 conference, experts from academia, government and the private sector in the US, Canada and Japan will exchange knowledge centering on clinical applications, bioethics and development of pediatric personalized medicine programs. The conference will begin on Wednesday evening, April 28 at 6 p.m., with a keynote speech delivered by Gregory Downing, DO, PhD, Office of the Secretary, US Department of Health and Human Services.

Among the clinical applications to be discussed are some of the research programs being conducted at Children's Mercy addressing important patient challenges, such as:

  • Applying genomic strategies to improve the safety and efficacy of medications used to treat cancer in children
  • Improving the effectiveness and benefit/risk ratio of a common therapeutic agent in treating Juvenile Idiopathic Arthritis, where inter-patient variability results in up to 40 percent of patients failing to achieve remission
  • Uncovering genetic and developmental factors contributing to the risk of serious adverse drug reactions in children
  • Identifying a non-invasive marker for inflammation related to asthma, enabling physicians to accurately predict if patients will respond to steroid treatment, and if not, to guide them toward more useful therapies
  • Using genetic biomarkers to predict which newborns are at risk for developing hyperbilirubinemia, the single most common reason for newborn re-hospitalizations, accounting for up to 85 percent of readmissions during the first two weeks of life

The conference also will facilitate exchanges that help navigate concerns posed by personalized medicine. "Genetic discrimination, cost-benefit analysis, universal standards for managing genomic information in electronic medical records, biobanking, and strategies to educate practitioners and patients are all hot topics in personalized medicine that we will focus on at the conference," said conference organizer J. Steven Leeder, PharmD, PhD, Division Chief, Clinical Pharmacology and Medical Toxicology; Marion Merrell Dow Endowed Chair in Pediatric Clinical Pharmacology; and Professor of Pediatrics and Pharmacology, UMKC School of Medicine. "The importance of this area is also recognized by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has approved a grant to provide partial support for the meeting."


'/>"/>

Contact: Sherry D. Gibbs
SDGibbs@cmh.edu
816-346-1340
GolinHarris NY
Source:Eurekalert

Related medicine news :

1. Leading Orthopaedic Surgeon and Regenerative Medical Authority Dr. Thomas A. Einhorn Advances Adult Stem Cell Therapy To Eliminate Hip Replacement Surgery
2. South Carolina Senate Banking & Insurance Committee Advances Medigap Bill to Full Senate by Overwhelming Vote
3. Fifty years of the light fantastic: Laser advances spark scientific progress
4. Greenway Medical Technologies Advances Patient-Provider Benefits
5. SeqWright Advances Genomic Discovery With Isilon IQ
6. Neutrons poised to play big role in future scientific advances
7. Senate Committee Advances Disastrous Idaho Health Freedom Act
8. Sunquest Advances Investment in Innovations Team
9. Large donation advances cancer research
10. Medical Advances Revolutionize Hip Replacement and Knee Replacement
11. Gene Findings in Autism, Blindness at Childrens Hospital Top National Lists of Medical Advances in 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... 2016 , ... Miami Dental Specialists is excited to bring patients the choice ... in January, Miami Dental Specialists will offer the non-metal implants as a safe, holistic ... be chosen by the dental implant manufacturer, Straumann, to bring this cutting-edge technology to ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... ... “Revolutionizing Cancer Care.” , The print component of “Revolutionizing Cancer Care” ... Pittsburgh/Cleveland, New York, Washington DC/Baltimore, and Seattle, with a circulation of approximately 250,000 ...
(Date:2/12/2016)... ... 12, 2016 , ... Homeowners now have a next generation ... America’s leading brand of building products, has improved upon its industry-best array of ... version of the ColorView® Exterior Style and Color Selector. Created expressly for the ...
(Date:2/12/2016)... ... ... Healthcare careers in the medical laboratory, nursing, and in the imaging field ... staffing leader Aureus Medical Group during the month of January. Aureus Medical specializes in ... and in travel and direct hire opportunities in other allied health fields. , The ...
(Date:2/12/2016)... ... February 12, 2016 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... what he says are the real facts surrounding all those Bible stories. For generations ... Sunday school teachers, and Yisrayl says there is more to these than just mere ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... Kalifornien, 12. Februar 2016  Sequent Medical, Inc. ... von Patienten für eine Studie zur Sicherheit und ... speziell für die Behandlung von rupturierten intrakraniellen Aneurysmen ... Leiter der Neuroradiologie an der Universitätsklinik Bicètre in ... der CLARYS-Studie hat den ersten Patienten aufgenommen. ...
(Date:2/12/2016)... 2016  Eli Lilly and Company (NYSE: LLY ) ... (pemetrexed disodium) vitamin regimen patent would not presently be infringed ... France , Italy and ... only with dextrose solution.  --> ... of Appeal held that Lilly,s patent would be indirectly infringed ...
(Date:2/12/2016)... February 12, 2016 ... auf den ungedeckten medizinischen Bedarf bei Lungen- ... seines klinischen Forschungsprogramms bekannt. Das Programm, das ... Verbesserungen ihrer respiratorischen Funktionen und anderer klinischer ... ein Medizintechnikunternehmen, das sich auf den ungedeckten ...
Breaking Medicine Technology: